Table 2.
Soluble HSP70 levels in the sera of 142 patients with colorectal cancer without distant metastasis, according to stages of the disease or grade of cancer
| Stage or grade | Number of patients | Soluble HSP70, ng/ml median (25th–75th percentile) | p values Kruskal–Wallis test |
|---|---|---|---|
| TNM-T | 37 | ||
| 0, 1 or 2 | 92 | 1.68 (1.32-2.17) | |
| 3 | 9 | 1.60 (1.14-2.36) | 0.540 |
| 4 | 4 | 1.57 (0.99-2.74) | |
| Not available | |||
| TNM-N | |||
| 0 | 68 | 1.60 (1.18-2.15) | |
| 1 | 54 | 1.73 (1.24-2.71) | 0.581 |
| 2 | 14 | 1.55 (1.21-2.14) | |
| Not available | 6 | ||
| Grade of cancer | |||
| Low (1 or 2) | 90 | 1.58 (1.1.7) | |
| High (3) | 22 | 1.94 (1.44) | 0.078a |
| Not available | 30 |
aMann–Whitney test